CM
ATOS icon

Caption Management’s Atossa Therapeutics ATOS Stock Holding History

Caption Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,000
Closed -$66K – 1194
2023
Q4 		$66K Hold
5,000
– – ﹤0.01% 1209
2023
Q3 		$55.2K Hold
5,000
– – ﹤0.01% 1186
2023
Q2 		$94.5K Hold
5,000
– – ﹤0.01% 984
2023
Q1 		$54.4K Buy
+5,000
New +$55.8K ﹤0.01% 991
2022
Q1 		– Sell
-20,000
Closed -$480K – 1448
2021
Q4 		$480K Buy
20,000
+12,220
+157% +$447K 0.01% 1257
2021
Q3 		$380K Sell
7,780
-21,967
-74% -$1.28M ﹤0.01% 1250
2021
Q2 		$2.82M Buy
29,747
+24,080
+425% +$1.27M 0.04% 560
2021
Q1 		$179K Buy
+5,667
New +$207K ﹤0.01% 928

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Caption Management's ATOS Position: Q1 2022 in Review

Caption Management sold out of Atossa Therapeutics (ATOS) in Q1 2022, closing a stake of 8 shares.

Caption Management first reported a position in ATOS in Q2 2021 and held it in 3 quarters. The position peaked at $463K in Q3 2021. 83 funds tracked by Wall St. Rank hold ATOS as of Q1 2022.

  • Caption Management reported no remaining Atossa Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Caption Management sold 8 Atossa Therapeutics shares in Q1 2022.
  • Caption Management first reported a position in Atossa Therapeutics in Q2 2021 and held it in 3 quarters.
  • Caption Management's Atossa Therapeutics position peaked at $463K in Q3 2021.
  • 83 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2022.

Based on Caption Management's 13F filing for Q1 2022, filed 13 May 2022.